← Back to Clinical Trials
Recruiting NCT06131931

NCT06131931 HIV Prevention Intervention for Latino Male Couples

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06131931
Status Recruiting
Phase —
Sponsor University of Central Florida
Condition HIV
Study Type INTERVENTIONAL
Enrollment 400 participants
Start Date 2023-06-21
Primary Completion 2028-06

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age 100 Years
Study Type INTERVENTIONAL
Interventions
CLP InterventionWP Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 400 participants in total. It began in 2023-06-21 with a primary completion date of 2028-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The primary objective of this proposal is to test the efficacy of Connecting Latinxs en Pareja (CLP). CLP is a four-session intervention grounded in social cognitive theory and a relationship oriented ecological framework. The investigators will examine whether participants assigned to CLP report an increase in the proportion of HIV protected anal sex acts to those assigned to a Wellness Promotion (WP) time and attention matched control condition. The primary outcome, relates to use of HIV protection.

Eligibility Criteria

Inclusion Criteria: * at least 18 years * reside in the 50 local jurisdictions identified by the EHE initiative or 17 jurisdictions with most HIV diagnoses among Latinxs * identify as Latinx/Hispanic/Afro-Latinx or reports having a main partner who identifies as Latinx/Hispanic/Afro-Latin * report having a main/primary male partner operationalized as a man with whom he has a primary ongoing sexual relationship, for at least 3 months * at least one member of the dyad report three acts of unprotected of anal sex (with main or other partners) * able to speak English and/or Spanish Exclusion Criteria: Either partner: * reports severe intimate partner violence (IPV) within the dyad during the past year on the Revised Conflict Tactic Scale\[1-4\] * has a language or cognitive impairment that would prevent informed consent. Inclusion of dyads reporting severe IPV could pose dangers and ethical concerns and will be referred to domestic abuse organizations for screening and services. * adults unable to consent * pregnant women * prisoners * individuals who are not yet adults

Contact & Investigator

Central Contact

Omar Martinez, JD, MPH, MS

✉ omar.martinez@ucf.edu

📞 4072668742

Frequently Asked Questions

Who can join the NCT06131931 clinical trial?

This trial is open to male participants only, aged 18 Years or older, up to 100 Years, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06131931 currently recruiting?

Yes, NCT06131931 is actively recruiting participants. Contact the research team at omar.martinez@ucf.edu for enrollment information.

Where is the NCT06131931 trial being conducted?

This trial is being conducted at Orlando, United States.

Who is sponsoring the NCT06131931 clinical trial?

NCT06131931 is sponsored by University of Central Florida. The trial plans to enroll 400 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology